相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。SARS-CoV-2 variants and ending the COVID-19 pandemic
Arnaud Fontanet et al.
LANCET (2021)
Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Katharine H. D. Crawford et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
A new coronavirus associated with human respiratory disease in China
Fan Wu et al.
NATURE (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
Alexander E. Gorbalenya et al.
NATURE MICROBIOLOGY (2020)
The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines
Weilong Shang et al.
NPJ VACCINES (2020)
Progress and Concept for COVID-19 Vaccine Development
Suh-Chin Wu
BIOTECHNOLOGY JOURNAL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Chuan Qin et al.
CLINICAL INFECTIOUS DISEASES (2020)
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Zhe Xu et al.
LANCET RESPIRATORY MEDICINE (2020)
Herd Immunity: Understanding COVID-19
Haley E. Randolph et al.
IMMUNITY (2020)
Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China
Mingkai Tan et al.
IMMUNOLOGY (2020)
Recurrence of positive SARS-CoV-2 RNA in COVID-19: A case report
Dabiao Chen et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Effect of a Chikungunya Virus-Like Particle Vaccine on Safety and Tolerability Outcomes A Randomized Clinical Trial
Grace L. Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
COVID-19 and Postinfection Immunity Limited Evidence, Many Remaining Questions
Robert D. Kirkcaldy et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Severe Coronavirus Disease-2019 in Children and Young Adults in the Washington, DC, Metropolitan Region
Roberta L. DeBiasi et al.
JOURNAL OF PEDIATRICS (2020)
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
Feng-Cai Zhu et al.
LANCET (2020)
Hyperinflammatory shock in children during COVID-19 pandemic
Shelley Riphagen et al.
LANCET (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
Linlin Bao et al.
NATURE (2020)
Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing
Wen Wen et al.
CELL DISCOVERY (2020)
Antibody responses to SARS-CoV-2 in patients with COVID-19
Quan-Xin Long et al.
NATURE MEDICINE (2020)
The COVID-19 vaccine development landscape
Tung Thanh Le et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
A Thermostable mRNA Vaccine against COVID-19
Na-Na Zhang et al.
CELL (2020)
Construction of SARS-CoV-2 Virus-Like Particles by Mammalian Expression System
Ruodan Xu et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19
Bicheng Zhang et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Pedro M. Folegatti et al.
LANCET (2020)
The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19
Camila Rosat Consiglio et al.
CELL (2020)
A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice
Jing Lu et al.
CELL RESEARCH (2020)
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
Mark J. Mulligan et al.
NATURE (2020)
Convergent antibody responses to SARS-CoV-2 in convalescent individuals
Davide F. Robbiani et al.
NATURE (2020)
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Quan-Xin Long et al.
NATURE MEDICINE (2020)
Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19
F. Javier Ibarrondo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy
Hongjing Gu et al.
SCIENCE (2020)
With Risk of Reinfection, Is COVID-19 Here to Stay?
Parnian Jabbari et al.
DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS (2020)
A candidate multi-epitope vaccine against SARS-CoV-2
Tamalika Kar et al.
SCIENTIFIC REPORTS (2020)
A leading coronavirus vaccine trial is on hold: scientists react
Nicky Phillips et al.
NATURE (2020)
Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection
Michael J. Carter et al.
NATURE MEDICINE (2020)
Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial
Ricardo Palacios et al.
TRIALS (2020)
Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals
Guillaume Beaudoin-Bussieres et al.
MBIO (2020)
Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients
Anita S. Iyer et al.
SCIENCE IMMUNOLOGY (2020)
Who should be prioritised for COVID-19 vaccines?
Zaki Hassan-Smith et al.
LANCET (2020)
COVID-19 and multisystem inflammatory syndrome in children and adolescents
Li Jiang et al.
LANCET INFECTIOUS DISEASES (2020)
Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients
Mehul S. Suthar et al.
CELL REPORTS MEDICINE (2020)
Immunological considerations for COVID-19 vaccine strategies
Mangalakumari Jeyanathan et al.
NATURE REVIEWS IMMUNOLOGY (2020)
The SARS-CoV-2 Vaccine Pipeline: an Overview
Wen-Hsiang Chen et al.
CURRENT TROPICAL MEDICINE REPORTS (2020)
Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2
Michele Catanzaro et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients
Baweleta Isho et al.
SCIENCE IMMUNOLOGY (2020)
Modulation of the immune response by Middle East respiratory syndrome coronavirus
Somayeh Shokri et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Tauroursodeoxycholic acid (TUDCA) inhibits influenza A viral infection by disrupting viral proton channel M2
Ning Li et al.
SCIENCE BULLETIN (2019)
The Multifaceted B Cell Response to Influenza Virus
Jonathan H. Lam et al.
JOURNAL OF IMMUNOLOGY (2019)
MERS, SARS and other coronaviruses as causes of pneumonia
Yudong Yin et al.
RESPIROLOGY (2018)
A Review of DNA Vaccines Against Influenza
Leo Yi Yang Lee et al.
FRONTIERS IN IMMUNOLOGY (2018)
Co-delivery of a CD4 T cell helper epitope via covalent liposome attachment with a surface-arrayed B cell target antigen fosters higher affinity antibody responses
Mostafa A. Elbahnasawy et al.
VACCINE (2018)
Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies
Marc Rondy et al.
JOURNAL OF INFECTION (2017)
Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate
Wen-Hsiang Chen et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Novel strategies in vaccine design: can nanocapsules help prevent and treat hepatitis B?
Stephan Gehring et al.
NANOMEDICINE (2017)
Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
Rudragouda Channappanavar et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
Expression and Cleavage of Middle East Respiratory Syndrome Coronavirus nsp3-4 Polyprotein Induce the Formation of Double-Membrane Vesicles That Mimic Those Associated with Coronaviral RNA Replication
Diede Oudshoorn et al.
MBIO (2017)
T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV
William J. Liu et al.
ANTIVIRAL RESEARCH (2017)
MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015
Pyoeng Gyun Choe et al.
EMERGING INFECTIOUS DISEASES (2017)
SARS and MERS: recent insights into emerging coronaviruses
Emmie de Wit et al.
NATURE REVIEWS MICROBIOLOGY (2016)
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
Shuo Su et al.
TRENDS IN MICROBIOLOGY (2016)
Adventitious agents and live viral vectored vaccines: Considerations for archiving samples of biological materials for retrospective analysis
Bettina Klug et al.
VACCINE (2016)
Middle East respiratory syndrome coronavirus M protein suppresses type I interferon expression through the inhibition of TBK1-dependent phosphorylation of IRF3
Pak-Yin Lui et al.
EMERGING MICROBES & INFECTIONS (2016)
SARS Coronavirus Papain-Like Protease Inhibits the TLR7 Signaling Pathway through Removing Lys63-Linked Polyubiquitination of TRAF3 and TRAF6
Shih-Wen Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus
Maximillian S. Habibi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds
Yahira M. Baez-Santos et al.
ANTIVIRAL RESEARCH (2015)
Interferon-Stimulated Genes: A Complex Web of Host Defenses
William M. Schneider et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease
Xingxing Yang et al.
JOURNAL OF GENERAL VIROLOGY (2014)
Distinct Immune Response in Two MERS-CoV-Infected Patients: Can We Go from Bench to Bedside?
Emmanuel Faure et al.
PLOS ONE (2014)
Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice
Christopher M. Coleman et al.
VACCINE (2014)
Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate
Wen-Hsiang Chen et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Middle East Respiratory Syndrome Coronavirus Accessory Protein 4a Is a Type I Interferon Antagonist
Daniela Niemeyer et al.
JOURNAL OF VIROLOGY (2013)
Liposomes containing monophosphoryl lipid A: A potent adjuvant system for inducing antibodies to heroin hapten analogs
Gary R. Matyas et al.
VACCINE (2013)
Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome
Shibo Jiang et al.
EXPERT REVIEW OF VACCINES (2012)
Antibody Dynamics of 2009 Influenza A (H1N1) Virus in Infected Patients and Vaccinated People in China
Ming Wang et al.
PLOS ONE (2011)
Severe Acute Respiratory Syndrome Coronavirus Papain-Like Protease Ubiquitin-Like Domain and Catalytic Domain Regulate Antagonism of IRF3 and NF-κB Signaling
Matthew Frieman et al.
JOURNAL OF VIROLOGY (2009)
T cell responses to whole SARS coronavirus in humans
Chris Ka-fai Li et al.
JOURNAL OF IMMUNOLOGY (2008)
SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum
Kevin Knoops et al.
PLOS BIOLOGY (2008)
Duration of humoral immunity to common viral and vaccine antigens
Ian J. Amanna et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Severe acute respiratory syndrome coronavirus evades antiviral signaling: Role of nsp1 and rational design of an attenuated strain
Marc G. Wathelet et al.
JOURNAL OF VIROLOGY (2007)
Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome
W Liu et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Neutralizing antibody response and SARS severity
MS Ho et al.
EMERGING INFECTIOUS DISEASES (2005)
Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis
CY Cheung et al.
JOURNAL OF VIROLOGY (2005)
Virus-encoded proteinases and proteolytic processing in the Nidovirales
J Ziebuhr et al.
JOURNAL OF GENERAL VIROLOGY (2000)
分享论文
